HER2gene status in primary breast cancers and matched distant metastases

Overview of attention for article published in Breast Cancer Research, May 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 2 policy sources

patent: 1 patent

Citations

dimensions_citation: 103 Dimensions

Readers on

mendeley: 64 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY

Application WO-2010132723-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.